4//SEC Filing
Stone Christopher Lewis 4
Accession 0000882104-19-000023
CIK 0000882104other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 5:10 PM ET
Size
5.9 KB
Accession
0000882104-19-000023
Insider Transaction Report
Form 4
Stone Christopher Lewis
VP and General Counsel
Transactions
- Award
Stock Option (right to buy)
2019-03-28+817,610→ 817,610 totalExercise: $3.72Exp: 2029-03-28→ Common stock (817,610 underlying)
Footnotes (1)
- [F1]The stock options will vest as follows: (a) 25% of the shares subject to the option shall vest on the one year anniversary of January 1, 2019 and (b) 75% of the shares subject to the option shall vest on a monthly basis pro rata over the thirty-six (36) months following the one year anniversary of January 1, 2019, provided that the recipient's continuous service has not terminated prior to the applicable vesting date, subject to earlier vesting upon a change in control and certain qualifying terminations of employment provided in the severance agreement between the issuer and the recipient.
Documents
Issuer
PDL BIOPHARMA, INC.
CIK 0000882104
Entity typeother
Related Parties
1- filerCIK 0001453373
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 5:10 PM ET
- Size
- 5.9 KB